The company was formerly known as Fountain Healthy Aging, Inc. and changed its name to Microalliance Group Inc. in February 2022. As an OTC-traded holding company, Microalliance operates in a competitive China-focused beverage and spirits market with low analyst coverage and limited institutional visibility. The company faces typical OTC market liquidity and disclosure challenges, though it maintains a diversified product portfolio across premium coffee and spirits segments.
Cyborg Score Rationale
Microalliance trades on OTC markets with minimal analyst coverage (0 analysts), limited public financial transparency, and a complex restructuring history. While the company operates in high-margin beverage/spirits categories in China, its extremely low trading volume, small employee base (30), and lack of recent financial guidance suggest significant operational and liquidity challenges.
Top Insights
OTC-traded micro-cap with no analyst coverage and minimal institutional interest
Diversified portfolio across premium coffee (specialty blends with Chinese tea taste profile) and liquor (baijiu and coffee spirits) targeting China market
Recent name change (February 2022) from Fountain Healthy Aging to Microalliance suggests portfolio repositioning toward beverages/spirits
Extremely small operational footprint (30 employees reported as of March 2026) raises questions about revenue scale and execution capacity
Named Competitors
Kweichow Moutai — Premium baijiu spirits producer and market leader in China
Luckin Coffee — China-based coffee chain and beverage retailer
Starbucks China — Global coffeehouse chain with significant China presence
Recent Developments
(February 2022) Company name changed from Fountain Healthy Aging, Inc. to Microalliance Group Inc.
Open the full interactive Microalliance Group Inc. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.